GLP-1 Price Guide Compare prices
Safety · June 1, 2026

What to Ask Before Buying Tirzepatide Online

Tirzepatide-specific verification. The dose-tier price schedule matters most for tirz.

Safety & RegulationJune 1, 2026Editorial
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework
  1. What is the price at 10-15 mg maintenance dose? (Most patients will be at maintenance most of the year.)
  2. Does the monthly rate change at each dose step (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg)?
  3. Is there a separate membership fee?
  4. Are provider visits, lab review, and shipping included?
  5. Which named pharmacy fills my tirzepatide prescription?
  6. Is the pharmacy licensed in its state? Verify through State Board of Pharmacy.
  7. What sterile compounding standards does the pharmacy follow (USP <797>, USP <800>)?
  8. What is the cancellation policy if I want to switch providers mid-treatment?
  9. What are the refill billing terms?
  10. Does the program work with my state of residence?

Sources reviewed

  • Provider pricing pages (live as of June 1, 2026)
  • Provider terms, refund, and support pages
  • Third-party pricing comparisons and analyst reports
  • FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
  • FDA — Compounding and the FDA: Questions and Answers
  • FDA — Drug Shortages database
  • DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
  • NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
  • Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
  • State Board of Pharmacy licensure lookups (varies by state)
  • Federation of State Medical Boards — FSMB DocInfo physician verification
  • LegitScript healthcare merchant directory (where applicable)
Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.